Abstract
The intestinal transepithelial elimination of ciprofloxacin was studied in a rabbit model. Jejunal, ileal, and cecal segments along with their intact blood vessels were isolated and perfused, and their contents were collected over a 120-min period following administration of a single parenteral dose of 27 mg of ciprofloxacin per kg of body weight. The intestinal elimination rates of ciprofloxacin were 0.126 +/- 0.084, 0.235 +/- 0.22, and 0.11 +/- 0.084 micrograms.min-1.cm-2 for the jejunal, ileal, and cecal segments, respectively. The calculated fractions of ciprofloxacin eliminated were 3.3 mg from the jejunum and 13.8 mg from the ileum, representing 19% of the administered dose. Additional amounts of 2.5 to 3.7 mg or 4.9 to 7.3% of the administered dose were eliminated from the cecum. Elimination was probably not due to a passive diffusion process but rather due to an active transepithelial transport. This intestinal elimination pattern of ciprofloxacin may explain the unusual activity of the fluoroquinolones in modifying the intestinal flora.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brumfitt W., Franklin I., Grady D., Hamilton-Miller J. M., Iliffe A. Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers. Antimicrob Agents Chemother. 1984 Nov;26(5):757–761. doi: 10.1128/aac.26.5.757. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hayashi T., Okada J., Kondo S., Yamazaki T. Role of intestinal excretion in the effect of subcutaneously administered sedecamycin on cecal infection caused by Treponema hyodysenteriae in mice. Antimicrob Agents Chemother. 1991 Aug;35(8):1601–1604. doi: 10.1128/aac.35.8.1601. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Holland D. R., Quay J. F. Intestinal secretion of erythromycin base. J Pharm Sci. 1976 Mar;65(3):417–419. doi: 10.1002/jps.2600650325. [DOI] [PubMed] [Google Scholar]
- Israili Z. H., Dayton P. G. Enhancement of xenobiotic elimination: role of intestinal excretion. Drug Metab Rev. 1984;15(5-6):1123–1159. doi: 10.3109/03602538409033559. [DOI] [PubMed] [Google Scholar]
- Puro V., Narciso P., Girardi E., Antonelli L., Zaccarelli M., Visco G. Male-to-female transmission of human immunodeficiency virus infection by oro-genital sex. Eur J Clin Microbiol Infect Dis. 1991 Jan;10(1):47–47. doi: 10.1007/BF01967102. [DOI] [PubMed] [Google Scholar]
- Sorgel F., Naber K. G., Kinzig M., Mahr G., Muth P. Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review. Am J Med. 1991 Dec 30;91(6A):51S–66S. doi: 10.1016/0002-9343(91)90312-l. [DOI] [PubMed] [Google Scholar]
- Sörgel F., Naber K. G., Jaehde U., Reiter A., Seelmann R., Sigl G. Gastrointestinal secretion of ciprofloxacin. Evaluation of the charcoal model for investigations in healthy volunteers. Am J Med. 1989 Nov 30;87(5A):62S–65S. doi: 10.1016/0002-9343(89)90025-9. [DOI] [PubMed] [Google Scholar]
- Westblom T. U., Duriex D. E., Madan E., Belshe R. B. Guinea pig model for antibiotic transport across gastric mucosa: inhibitory tissue concentrations of clindamycin against Helicobacter pylori (Campylobacter pylori) following two separate dose regimens. Antimicrob Agents Chemother. 1990 Jan;34(1):25–28. doi: 10.1128/aac.34.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Westblom T. U., Duriex D. E. Pharmacokinetics of cefuroxime and ciprofloxacin in gastric mucosa: comparison to in vitro inhibitory concentrations against Helicobacter pylori. Microbiologica. 1991 Jan;14(1):37–43. [PubMed] [Google Scholar]